KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Gains from Investment Securities (2016 - 2025)

Evolent Health has reported Gains from Investment Securities over the past 11 years, most recently at -$5.2 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at -$5.2 million for Q4 2025, down 178.41% from a year ago — trailing twelve months through Dec 2025 was -$3.3 million (down 121.22% YoY), and the annual figure for FY2024 was $15.7 million, up 9080.7%.
  • Gains from Investment Securities for Q4 2025 was -$5.2 million at Evolent Health, down from -$1.1 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for EVH hit a ceiling of $12.6 million in Q1 2023 and a floor of -$14.2 million in Q4 2023.
  • Median Gains from Investment Securities over the past 5 years was -$12500.0 (2021), compared with a mean of $263611.1.
  • Peak annual rise in Gains from Investment Securities hit 1123.23% in 2022, while the deepest fall reached 5544.44% in 2022.
  • Evolent Health's Gains from Investment Securities stood at -$3.8 million in 2021, then soared by 123.73% to $899000.0 in 2022, then tumbled by 1676.97% to -$14.2 million in 2023, then soared by 146.49% to $6.6 million in 2024, then plummeted by 178.41% to -$5.2 million in 2025.
  • The last three reported values for Gains from Investment Securities were -$5.2 million (Q4 2025), -$1.1 million (Q3 2025), and $3.2 million (Q2 2025) per Business Quant data.